Evidence map›Paper›PMID 38776267›Full record

ArticleNano letters2024

Interferometric Biosensor for High Sensitive Label-Free Recording of HiPS Cardiomyocytes Contraction

Alessio Boschi, Giuseppina Iachetta, Salvatore Buonocore, Aliaksandr Hubarevich, Julien Hurtaud, Rosalia Moreddu, Marta d'Amora, Maria Blanco Formoso, Francesco Tantussi, Michele Dipalo and 1 more

Abstract read
In one paragraph

Article in Nano letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alessio BoschiPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.ORCID 0009-0002-0593-0090
Giuseppina IachettaPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.
Salvatore BuonocorePlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.
Aliaksandr HubarevichPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.
Julien HurtaudPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.
Rosalia MoredduPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.ORCID 0000-0002-0332-1606
Marta d'AmoraPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.
Maria Blanco FormosoPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.
Francesco TantussiPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.ORCID 0000-0002-0812-082X
Michele DipaloPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.ORCID 0000-0002-1823-8231
Francesco De AngelisPlasmon Nanotechnologies Unit, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.ORCID 0000-0001-6053-2488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart disease remains a leading cause of global mortality, underscoring the need for advanced technologies to study cardiovascular diseases and develop effective treatments. We introduce an innovative interferometric biosensor for high-sensitivity and label-free recording of human induced pluripotent stem cell (hiPSC) cardiomyocyte contraction

Indexed as

Biosensing TechniquesInduced Pluripotent Stem CellsInterferometryMyocardial ContractionMyocytes, CardiacHumanscardiomyocytescardiotoxicitycontractionfluorescencein vitroOptical-cavity

Identifiers

PMID38776267
PMCPMC11157657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.